Fruquintinib: a novel antivascular endothelial growth factor receptor tyrosine kinase inhibitor for the treatment of metastatic colorectal cancer
Fruquintinib: a novel antivascular endothelial growth factor receptor tyrosine kinase inhibitor for the treatment of metastatic colorectal cancer
复制标题
DOI：
--
复制
发表时间：
2019
影响因子：
3.3
通讯作者：
Ying Wang
中科院分区：
文献类型：
--
作者：
Ying Zhang;Jia-Yun Zou;Zhe Wang;Ying Wang
